Literature DB >> 2667357

Observations on spiraling empiricism: its causes, allure, and perils, with particular reference to antibiotic therapy.

J H Kim1, H A Gallis.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2667357     DOI： 10.1016/s0002-9343(89)80697-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  10 in total

Review 1.  Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia.

Authors:  Victor L Yu; Nina Singh
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

2.  Drug cost containment at a large teaching hospital.

Authors:  P I Pillans; I Conry; B E Gie
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 3.  Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.

Authors:  Ephraim L Tsalik; Elizabeth Petzold; Barry N Kreiswirth; Robert A Bonomo; Ritu Banerjee; Ebbing Lautenbach; Scott R Evans; Kimberly E Hanson; Jeffrey D Klausner; Robin Patel
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 4.  Antibiotics for ventilator-associated pneumonia.

Authors:  Lauren E Arthur; Russell S Kizor; Adrian G Selim; Mieke L van Driel; Leonardo Seoane
Journal:  Cochrane Database Syst Rev       Date:  2016-10-20

5.  Assessing antibacterial pharmacoeconomics in the intensive care unit.

Authors:  M C Birmingham; J M Hassett; J J Schentag; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

6.  Host gene expression classifiers diagnose acute respiratory illness etiology.

Authors:  Ephraim L Tsalik; Ricardo Henao; Marshall Nichols; Thomas Burke; Emily R Ko; Micah T McClain; Lori L Hudson; Anna Mazur; Debra H Freeman; Tim Veldman; Raymond J Langley; Eugenia B Quackenbush; Seth W Glickman; Charles B Cairns; Anja K Jaehne; Emanuel P Rivers; Ronny M Otero; Aimee K Zaas; Stephen F Kingsmore; Joseph Lucas; Vance G Fowler; Lawrence Carin; Geoffrey S Ginsburg; Christopher W Woods
Journal:  Sci Transl Med       Date:  2016-01-20       Impact factor: 17.956

7.  Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?

Authors:  Mary-Anne W Aarts; Christian Brun-Buisson; Deborah J Cook; Anand Kumar; Steven Opal; Graeme Rocker; Terry Smith; Jean-Louis Vincent; John C Marshall
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

8.  Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM.

Authors:  Richard G Wunderink; Arjun Srinivasan; Philip S Barie; Jean Chastre; Charles S Dela Cruz; Ivor S Douglas; Margaret Ecklund; Scott E Evans; Scott R Evans; Anthony T Gerlach; Lauri A Hicks; Michael Howell; Melissa L Hutchinson; Robert C Hyzy; Sandra L Kane-Gill; Erika D Lease; Mark L Metersky; Nancy Munro; Michael S Niederman; Marcos I Restrepo; Curtis N Sessler; Steven Q Simpson; Sandra M Swoboda; Christina Vazquez Guillamet; Grant W Waterer; Curtis H Weiss
Journal:  Ann Am Thorac Soc       Date:  2020-05

9.  Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.

Authors:  Nicholas Bodkin; Melissa Ross; Micah T McClain; Emily R Ko; Christopher W Woods; Geoffrey S Ginsburg; Ricardo Henao; Ephraim L Tsalik
Journal:  Genome Med       Date:  2022-02-21       Impact factor: 11.117

10.  Gene expression-based classifiers identify Staphylococcus aureus infection in mice and humans.

Authors:  Sun Hee Ahn; Ephraim L Tsalik; Derek D Cyr; Yurong Zhang; Jennifer C van Velkinburgh; Raymond J Langley; Seth W Glickman; Charles B Cairns; Aimee K Zaas; Emanuel P Rivers; Ronny M Otero; Tim Veldman; Stephen F Kingsmore; Joseph Lucas; Christopher W Woods; Geoffrey S Ginsburg; Vance G Fowler
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.